“Diabetes mellitus type 2 reduces the viability, proliferation, and angiogenic marker of adipose-derived stem cells cultured in low-glucose anti-oxidant-serum supplemented medium” (2019) Biomedical Research and Therapy, 6(3), pp. 3073–3082. doi:10.15419/bmrat.v6i3.530.